KOLMAR
LIVE

Serial Number

97363780

Owner

KOLMAR HOLDINGS CO., LTD.

Attorney

David Youngjoon Jung

Filing Date

Apr 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

KOLMAR Trademark

Serial Number: 97363780 • Registration: 7404564

KOLMAR is a trademark filed by KOLMAR HOLDINGS CO., LTD. on April 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

KOLMAR HOLDINGS CO., LTD. (56 trademarks)

12-11, DEOKGOGAE-GIL
SEJONG-SI 30004 , KR

Entity Type: 03

KOLMAR KOREA HOLDINGS CO., LTD. (61 trademarks)

12-11, Deokgogae-gil,
Sejong-si 30004 , KR

Entity Type: 03

Trademark Details

Filing Date

April 14, 2022

Registration Date

June 4, 2024

Published for Opposition

March 19, 2024

Goods & Services

Nutraceuticals for use as a dietary supplement; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceutical preparations for the treatment of immune system related diseases and disorders, infectious diseases, metabolic diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, cancer and oncologic disorders, skin diseases and disorders, cardiovascular diseases, respiratory diseases, allergic diseases, neurological disorders and conditions, psychiatric disorders; dietary supplements; probiotic bacterial formulations for medical use; nutraceutical preparations mainly based on lactic acid bacteria; probiotic preparations for medical use; dietary supplements for humans; lacteal flour for babies; household deodorants; Medicines for human purposes, namely, for the treatment and relief of inflammation and inflammatory diseases and disorders; Medicines for human purposes, namely, antioxidants; Medicines for human purposes, namely, preparations for the treatment of allergies, hay fever, motion sickness, dermatologic use, namely, the treatment of dermatitis, skin pigmentation diseases, treatment of cold sores, treatment and prevention of dry skin, eczema, psoriasis, acne, for the treatment of atopic skin, the treatment of sunburn, irritated skin, cracking, cracks, insect bites, minor wounds, rashes, warts, for the treatment of diseases and symptoms within the central nervous system, namely, anxiety, spasms, sleep disorders, nervousness, irritability, nerves, apprehensiveness, emotional palpitations, for the treatment of disorders and conditions involving the joints, muscles, tendons and ligaments, for the treatment of joint pain, muscle, muscle fatigue, cramps, fatigue states, for the treatment of toothache, for the treatment of infections of the mouth, for the treatment of bruises, bumps, aches, pain, fever, headaches, vitamin-based nutritional supplements and mineral supplements; Medicines for human purposes, namely, bacterial and bacteriological preparations for medical purposes; disposable baby diapers; vitamin preparations; mineral food supplements; cultures of microorganisms for medical use; Dietetic substances, namely, infant formula and food for babies adapted for medical use; Dietetic substances, namely, beverages and food adapted for medical use; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparation for skin care; Pharmaceutical preparations for treatment of hepatitis; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of diseases of the endocrine system; Pharmaceutical preparations for urogenital organs; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations, namely, medicated toiletry preparations, medicated soaps, skin lotions for pharmaceutical purposes; Pharmaceutical preparations for respiratory organs; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceuticals, namely, antioxidants; Pharmaceutical agents affecting digestive organs; Pharmaceuticals, namely, antibiotics and anti-infectives for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; Pharmaceuticals preparations and substances for the treatment of pain, inflammation, damaged skin and tissues and wounds; Pharmaceuticals preparations and substances for use in treating dermatitis, eczema, psoriasis, ulcerating wounds, skin diseases, skin conditions and lesions; Pharmaceutical skin lotions; probiotic supplements; preparations of microorganisms for medical or veterinary use; nutritional supplements

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 26, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2026 REAP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 17, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 17, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2025 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 6, 2024 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 4, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
CASE RETURNED TO EXAMINATION
Jan 16, 2024 OTHE
NOTICE OF ALLOWANCE CANCELLED
Jan 16, 2024 IUCN
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 7, 2023 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Dec 7, 2023 PCBG
ASSIGNED TO PETITION STAFF
Dec 7, 2023 APET
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 10, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 8, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 8, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 8, 2023 EEXT
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 8, 2023 EPPA
TEAS PETITION TO AMEND BASIS RECEIVED
Nov 8, 2023 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2023 CNSA
ASSIGNED TO EXAMINER
Jan 31, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2022 NWOS
NEW APPLICATION ENTERED
Apr 18, 2022 NWAP